mRNA technology: Facts and figures
Is mRNA technology only used for immune-related diseases? Who are the pioneers in this sector? A market overview.
Lipid nanoparticles for the medicine of the future
Why are LNPs so important for mRNA active ingredients? An interview with Dr. Andrea Engel.
Transportation via polymers
Evonik and Stanford University are cooperating in a search for new carrier substances for mRNA vaccines.
USA: Endless opportunities
The USA is a pioneer when it comes to important future technologies—and that’s one reason why it’s Evonik’s second home.